Literature DB >> 10369469

AMP is a partial agonist at the sheep cardiac ryanodine receptor.

L L Ching1, A J Williams, R Sitsapesan.   

Abstract

We have investigated the ability of AMP to modulate the native sheep cardiac ryanodine receptor (RyR) channel at various cytosolic [Ca2+]. Channels were incorporated into planar phospholipid bilayers and current fluctuations through the bilayer were monitored under voltage clamp conditions. We demonstrate that AMP only exhibits agonist activity if the cytosolic [Ca2+] is sufficiently high. Even in the presence of a high cytosolic [Ca2+] (65 microM), AMP cannot fully open the channel and the maximum open probability (Po) observed is approximately 0.3 at 2 mM AMP. Concentrations of AMP above the maximally activating level cause inactivation of the channel. Our experiments indicate that AMP is an agonist with such low efficacy at the ATP sites on the cardiac RyR that it is effectively an antagonist of ATP-induced increases in Po. Our study demonstrates that the number of phosphates attached to the 5'-carbon of the ribose ring of adenine-based compounds determines the efficacy of the ligand to increase the Po of the cardiac RyR. Substitution of groups at this position may lead to the identification of potent antagonists at ATP sites on RyR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369469      PMCID: PMC1565978          DOI: 10.1038/sj.bjp.0702491

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Adenosine(5')hexaphospho(5')adenosine stimulation of a Ca(2+)-induced Ca(2+)-release channel from skeletal muscle sarcoplasmic reticulum.

Authors:  H Morii; M Makinose
Journal:  Eur J Biochem       Date:  1992-05-01

2.  Quantitative description of three modes of activity of fast chloride channels from rat skeletal muscle.

Authors:  A L Blatz; K L Magleby
Journal:  J Physiol       Date:  1986-09       Impact factor: 5.182

3.  Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.

Authors:  P M Dunn; A G Blakeley
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

4.  Effects of simulated ischemia and reperfusion on the sarcoplasmic reticulum of digitonin-lysed cardiomyocytes.

Authors:  C M Hohl; A A Garleb; R A Altschuld
Journal:  Circ Res       Date:  1992-04       Impact factor: 17.367

5.  Activation of the sheep cardiac sarcoplasmic reticulum Ca(2+)-release channel by analogues of sulmazole.

Authors:  S J McGarry; A J Williams
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

6.  Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.

Authors:  C H Hoyle; G E Knight; G Burnstock
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

7.  Sheep cardiac sarcoplasmic reticulum calcium-release channels: modification of conductance and gating by temperature.

Authors:  R Sitsapesan; R A Montgomery; K T MacLeod; A J Williams
Journal:  J Physiol       Date:  1991-03       Impact factor: 5.182

8.  Adenosine discriminates between the caffeine and adenine nucleotide sites on the sheep cardiac sarcoplasmic reticulum calcium-release channel.

Authors:  S J McGarry; A J Williams
Journal:  J Membr Biol       Date:  1994-01       Impact factor: 1.843

9.  Cyclic ADP-ribose competes with ATP for the adenine nucleotide binding site on the cardiac ryanodine receptor Ca(2+)-release channel.

Authors:  R Sitsapesan; S J McGarry; A J Williams
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

10.  Single channel measurements of the calcium release channel from skeletal muscle sarcoplasmic reticulum. Activation by Ca2+ and ATP and modulation by Mg2+.

Authors:  J S Smith; R Coronado; G Meissner
Journal:  J Gen Physiol       Date:  1986-11       Impact factor: 4.086

View more
  5 in total

1.  Regulation of the calcium release channel from rabbit skeletal muscle by the nucleotides ATP, AMP, IMP and adenosine.

Authors:  D R Laver; G K Lenz; G D Lamb
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

2.  Structural factors that determine the ability of adenosine and related compounds to activate the cardiac ryanodine receptor.

Authors:  W M Chan; W Welch; R Sitsapesan
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  Diadenosine pentaphosphate is a potent activator of cardiac ryanodine receptors revealing a novel high-affinity binding site for adenine nucleotides.

Authors:  L Song; S M Carter; Y Chen; R Sitsapesan
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

4.  Luminal Ca2+ controls activation of the cardiac ryanodine receptor by ATP.

Authors:  Barbora Tencerová; Alexandra Zahradníková; Jana Gaburjáková; Marta Gaburjáková
Journal:  J Gen Physiol       Date:  2012-08       Impact factor: 4.086

5.  Promiscuous attraction of ligands within the ATP binding site of RyR2 promotes diverse gating behaviour.

Authors:  Chris Lindsay; Mano Sitsapesan; Wei Mun Chan; Elisa Venturi; William Welch; Maria Musgaard; Rebecca Sitsapesan
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.